HRP-catalyzed Mn(II) chelate-doped PDA/CaCO3 nanoparticles for tirapazamine delivery in imaging-guided tumor therapy

Puntos clave

• Effective tirapazamine delivery enhances tumor targeting, improving imaging-guided therapy outcomes.
• Key evidence shows HRP-catalyzed manganese chelate nanoparticles facilitate efficient drug delivery.
• Assessment using Mn(II) chelate-doped PDA/CaCO3 nanoparticles supports enhanced imaging capabilities for treatment.
• These findings may enable improved therapeutic options, highlighting the need for further clinical exploration.